Edition:
United Kingdom

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

121.60CHF
8:03am GMT
Change (% chg)

CHF0.80 (+0.66%)
Prev Close
CHF120.80
Open
CHF120.40
Day's High
CHF121.60
Day's Low
CHF120.40
Volume
2
Avg. Vol
6,011
52-wk High
CHF179.00
52-wk Low
CHF115.00

Chart for

About

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as... (more)

Overall

Beta: 0.44
Market Cap(Mil.): CHF2,027.75
Shares Outstanding(Mil.): 12.65
Dividend: 1.30
Yield (%): 0.81

Financials

  YPSN.S Industry Sector
P/E (TTM): 43.72 32.18 34.39
EPS (TTM): 3.67 -- --
ROI: 15.36 13.76 14.96
ROE: 16.24 16.50 16.52

BRIEF-Ypsomed Holding H1 Operating Result Amounts To CHF 68.4 Mln

* INCREASED SALES BY CHF 45.3 MILLION IN FIRST HALF YEAR OF 2018/19

06 Nov 2018

BRIEF-Philips And Ypsomed Partner On Development Of New Digital Services

* YPSOMED TEAMS UP WITH PHILIPS FOR THE DEVELOPMENT OF ITS NEW DIGITAL SERVICES

04 Oct 2018

BRIEF-Ypsomed Teams Up With Philips For Development Of New Digital Services To Simplify Medication Adherence Monitoring

* YPSOMED TEAMS UP WITH PHILIPS FOR DEVELOPMENT OF ITS NEW DIGITAL SERVICES TO SIMPLIFY MEDICATION ADHERENCE MONITORING Source text for Eikon: Further company coverage: (Gdynia Newsroom)

04 Oct 2018

BRIEF-Ypsomed Partners With JDRF To Develop New Open Technologies

* YPSOMED PARTNERS WITH JDRF TO DEVELOP NEW OPEN TECHNOLOGIES Source text - https://bit.ly/2NmYPby Further company coverage: (Gdynia Newsroom)

28 Aug 2018

Earnings vs. Estimates